v3.26.1
Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Stock options $ 394 $ 280
Transaction Costs 397 393
Research & Development 1,682 671
Accruals 27 141
Net operating loss carryforward 6,519 2,970
Valuation allowance (9,019) (4,455)
Net deferred income tax asset
Total deferred tax liabilities
Net deferred income tax liability